Gathering Views Valproate Experience

Published: 10/04/25

Healthcare Improvement Scotland are gathering views and experiences from people currently taking Valproate, or those who have recently stopped.

---

The engagement will continue until the end of June. This work will support health boards to develop action plans linked to the new regulatory measures for Valproate, whilst ensuring person-centred, safe, and effective implementation of new measures. The team are keen to reach a wide range of patients across Scotland. If you can support them to reach more patients, please get in touch at his.engagementevidence@nhs.scot. Please see the attached flyer to circulate to patients if possible.

You can find out more about this work on our website: 

Background Information

Healthcare Improvement Scotland would like to talk to people about their experience taking Valproate. Medication that contains Valproate could include: Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell.

We are looking to talk with people who are:

• currently taking Valproate or have stopped taking Valproate since August 2023

• able to become pregnant or get someone pregnant if not on contraception

• between 12 - 55 years old

  or

• carers of people with the above characteristics

We are keen to talk with people who have different characteristics and backgrounds.  

This work will inform NHS board plans for the safe use of Valproate. This will ensure person-centred, safe, and effective implementation of new measures.

If you would like to find out more or would like to take part, please email us at his.engagementevidence@nhs.scot.

Discussions will take place until June 2025.

---